Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR183 | P32249 | 5/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13636161 | 0.86 | GPR183 (0.57) | GPR183ALDH1A1SMN1; SMN2TDP1KMT2A | |
| SCHEMBL4377423 | 0.86 | GPR183 (0.57) | GPR183ALDH1A1SMN1; SMN2TDP1KMT2A | |
| SCHEMBL16598797 | 0.83 | GPR183 (1.00) | GPR183ALDH1A1SMN1; SMN2TDP1KMT2A | |
| SCHEMBL16598795 | 0.83 | GPR183 (1.00) | GPR183ALDH1A1SMN1; SMN2TDP1KMT2A | |
| SCHEMBL27295942 | 0.83 | GPR183 (0.74) | GPR183ALDH1A1SMN1; SMN2TDP1KMT2A | |
| SCHEMBL1612931 | 0.82 | HSD17B3 (0.61) | GPR183ALDH1A1SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL1612928 | 0.82 | HSD17B3 (0.61) | GPR183ALDH1A1SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL2485549 | 0.78 | GPR183 (0.67) | GPR183ALDH1A1SMN1; SMN2TDP1KMT2A | |
| SCHEMBL13636003 | 0.78 | GPR183 (0.57) | GPR183ALDH1A1SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL4380647 | 0.78 | GPR183 (0.57) | GPR183ALDH1A1SMN1; SMN2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080113968-A1 | Substituted piperazines and diazepanes | NOVO NORDISK A/S (DK) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080113968-A1 | Substituted piperazines and diazepanes | HRH3, HRH4, HRH1 | GPR183 264/4885ALDH1A1 1907/4885SMN1; SMN2 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.